McKesson Debt to Equity Ratio 2010-2024 | MCK

Current and historical debt to equity ratio values for McKesson (MCK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. McKesson debt/equity for the three months ending June 30, 2024 was 0.00.
McKesson Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $73.05B $-1.38B -52.90
2024-03-31 $69.04B $-1.60B -43.18
2023-12-31 $68.19B $-1.68B -40.54
2023-09-30 $67.56B $-1.46B -46.14
2023-06-30 $65.34B $-1.24B -52.69
2023-03-31 $63.81B $-1.49B -42.83
2022-12-31 $64.78B $-2.09B -31.01
2022-09-30 $64.33B $-1.25B -51.51
2022-06-30 $63.77B $-1.47B -43.32
2022-03-31 $65.09B $-1.79B -36.32
2021-12-31 $64.50B $-0.79B -81.95
2021-09-30 $63.69B $-0.09B -732.05
2021-06-30 $62.94B $-0.05B -1398.64
2021-03-31 $64.84B $0.18B 370.51
2020-12-31 $62.12B $-0.28B -224.27
2020-09-30 $55.47B $6.09B 9.11
2020-06-30 $52.01B $5.65B 9.20
2020-03-31 $55.94B $5.31B 10.54
2019-12-31 $54.49B $6.39B 8.53
2019-09-30 $52.30B $6.69B 7.82
2019-06-30 $53.61B $8.07B 6.65
2019-03-31 $51.39B $8.29B 6.20
2018-12-31 $51.62B $9.39B 5.50
2018-09-30 $51.89B $9.53B 5.44
2018-06-30 $51.64B $9.65B 5.35
2018-03-31 $50.32B $10.06B 5.00
2017-12-31 $52.24B $11.97B 4.36
2017-09-30 $52.48B $11.36B 4.62
2017-06-30 $50.30B $11.51B 4.37
2017-03-31 $49.70B $11.27B 4.41
2016-12-31 $50.02B $7.85B 6.37
2016-09-30 $48.69B $9.62B 5.06
2016-06-30 $48.41B $9.49B 5.10
2016-03-31 $47.52B $9.01B 5.28
2015-12-31 $46.13B $8.96B 5.15
2015-09-30 $46.95B $8.87B 5.29
2015-06-30 $46.99B $8.94B 5.26
2015-03-31 $45.79B $8.09B 5.66
2014-12-31 $45.95B $9.16B 5.02
2014-09-30 $41.71B $10.53B 3.96
2014-06-30 $42.24B $10.77B 3.92
2014-03-31 $41.44B $10.32B 4.02
2013-12-31 $28.45B $8.03B 3.55
2013-09-30 $27.96B $7.99B 3.50
2013-06-30 $28.08B $7.41B 3.79
2013-03-31 $27.72B $7.07B 3.92
2012-12-31 $25.78B $7.65B 3.37
2012-09-30 $25.25B $7.72B 3.27
2012-06-30 $24.55B $7.20B 3.41
2012-03-31 $26.26B $6.83B 3.85
2011-12-31 $25.70B $7.46B 3.45
2011-09-30 $24.79B $7.12B 3.48
2011-06-30 $24.10B $6.92B 3.48
2011-03-31 $23.67B $7.22B 3.28
2010-12-31 $23.32B $7.08B 3.29
2010-09-30 $19.98B $6.82B 2.93
2010-06-30 $20.52B $6.88B 2.98
2010-03-31 $20.66B $7.53B 2.74
2009-12-31 $20.42B $7.12B 2.87
2009-09-30 $19.91B $6.72B 2.96
2009-06-30 $19.45B $6.27B 3.10
2009-03-31 $19.07B $6.19B 3.08
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $71.233B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95